This article is more than 5 years old. Information may no longer be current.
Orthopedic society launched to promote research, use of biologic treatments
Click Here to Manage Email Alerts
The first international society dedicated to the evaluation and use of new biologic treatments for orthopedic conditions was introduced yesterday prior to the start of the American Academy of Orthopaedic Surgeons (AAOS) 76th Annual Meeting.
The Biologic Orthopaedic Society (BOS) held its inaugural meeting Tuesday at the Venetian Hotel in Las Vegas immediately preceding the AAOS meeting. BOS presiding founders Allan Mishra, MD, from Stanford University Medical Center, Stanford, Calif.; and Pietro S. Randelli, MD, of the Université degli Studi di Milano, Milan, Italy, co-chaired the meeting of 12 internationally renowned orthopedic researchers.
“Regenerative medicine and biologics are pushing orthopedics into new and exciting directions,” Mishra said in a press release. “But until we formed the BOS, no one group represented a vibrant research community that is hard at work developing these applications for orthopedic use.”
“BOS is a collaborative effort of several eminent scientists who recognize the immense potential of biologics to improve orthopedic care,” Randelli added in a statement. “We want to share what we have learned in our own labs, to compare results, collaborate on promising treatments and disseminate this important information to the orthopedic community at large.”
Members’ research interests include stem cell therapy for osteoarthritis and other musculoskeletal conditions; platelet-rich plasma injections for chronic tendonitis, disc regeneration and accelerated healing; molecular and cell biology and biomaterials for tendon-to-bone healing; and recombinant bone morphogenetic proteins to repair fresh fractures. Current research suggests that these biologic treatments may be used alone or in combination for optimal effect.
Membership in the society is by invitation only and will be extended to researchers who have considerable expertise in and a demonstrated commitment to the investigation of new and emerging biologic techniques, according to the press release. The BOS maintains a members-only Web site and is planning to launch an online journal. At the moment, the BOS is privately funded.
For more information:
- The Biologic Orthopaedic Society can be reached at www.BiologicOrtho.com; by e-mail: info@biologicortho.com; or contact Patti Davis, MPH, of Davis MedPR Inc. at 630-920-8042 or by e-mail: patti@davismedpr.com.